© 2021 MJH Life Sciences and Psychiatric Times. All rights reserved.
© 2021 MJH Life Sciences™ and Psychiatric Times. All rights reserved.
July 19, 2021
After the largest increase in overdose deaths in 50 years, the American Psychiatric Association sends out the call for improved substance use care.
July 15, 2021
Novel digital therapy modia will be evaluated in combination with sublingual buprenorphine/naloxone background therapy to see whether it is superior in reducing opioid use.
The potential role of eye movement desensitization and reprocessing.
July 13, 2021
Cannabis has been heralded as a treatment for many conditions, but what about its psychiatric risks?
July 09, 2021
To combat drug overdoses, the Rhode Island governor signed a bill allowing people to consume pre-obtained drugs under safe, professional supervision of trained staff.
July 01, 2021
Yes, we need better crisis management, but what we really need is better crisis prevention.
June 23, 2021
The enduring racial gap in the opiate addiction rate stems largely from racist 19th-century medical beliefs about Black bodies, coupled with substandard medical care provided to Black Civil War troops.
June 22, 2021
Adial’s AD04 for the treatment of alcohol use disorder received a Notice of Allowance from the US Patent and Trademark Office.
June 15, 2021
The Drug Policy Reform Act, introduced today, intends to decriminalize drug use and possession, providing health-centered approaches and rehabilitation instead.
June 11, 2021